证券记录 · 已归档季度
RMD
ResMed Inc. · Healthcare · Medical - Instruments & Supplies
21被追踪持有人
0Δ持有人
49.43M持有股份
$13.53B报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +2.9% · 净新建仓位 -4.8% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 196.75K | $33.94M | n/a | n/a |
| Q2 2026 | 157 | +2 | 75.82M | $14.78B | +7 | −6 |
| Q1 2026 | 159 | +3 | 74.11M | $16.62B | +5 | −3 |
| Q4 2025 | 155 | -2 | 83.70M | $20.16B | +1 | −2 |
| Q3 2025 | 21 | 0 | 49.43M | $13.53B | n/a | −1 |
| Q2 2025 | 19 | +1 | 44.83M | $11.56B | +1 | n/a |
| Q1 2025 | 15 | -1 | 12.96M | $2.90B | n/a | −1 |
| Q4 2024 | 16 | -2 | 12.69M | $2.90B | n/a | −2 |
| Q3 2024 | 17 | +2 | 6.96M | $1.70B | +2 | n/a |
| Q2 2024 | 15 | n/a | 5.93M | $1.13B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 19.04M | +1.6% | $5.21B | 0.1% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 12.28M | -1.3% | $3.36B | 0.1% | ▼ Trim | 2 | SEC ↗ ×21 |
| 3 | State Street Global Advisors ✦ (被动) | 6.55M | -1.0% | $1.79B | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 4.25M | +0.9% | $1.16B | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Morgan Stanley ✦ | 2.31M | n/a | $633.18M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 6 | JPMorgan Chase ✦ | 1.23M | n/a | $338.05M | 0.0% | n/c | 1 | SEC ↗ ×34 |
| 7 | Fidelity (FMR) ✦ | 880.31K | +155.3% | $240.97M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 8 | Goldman Sachs Group ✦ | 860.79K | n/a | $235.62M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 9 | T. Rowe Price ✦ | 772.19K | +125.0% | $211.37M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Marshall Wace ✦ | 310.99K | +2373.1% | $85.13M | 0.1% | ▲ Add | 6 | SEC ↗ ×3 |
| 11 | AQR Capital Management ✦ | 222.11K | +19.1% | $60.77M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 12 | Citadel Advisors ✦ | 192.59K | -47.6% | $52.72M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 13 | Arrowstreet Capital ✦ | 100.00K | +6535.9% | $27.37M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Millennium Management ✦ | 89.81K | -1.7% | $24.58M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | Wellington Management ✦ | 69.47K | -9.9% | $19.02M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 16 | Fisher Asset Management ✦ | 60.78K | +30.0% | $16.64M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 58.00K | -43.7% | $15.88M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 50.70K | +334.5% | $13.88M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 19 | Adage Capital Partners ✦ | 42.53K | +1926.2% | $11.64M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Bridgewater Associates ✦ | 31.98K | +508.7% | $8.75M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 24.72K | -11.0% | $6.77M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Norges Bank | $306.45M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 932 持有人, 96.37M 股份, $21.06B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 07
Farrell Michael J.
Officer, Director · 4.99K 股 · $1.13M
Sep 08
Farrell Michael J.
Officer, Director · 4.99K 股 · $1.11M
Sep 02
FARRELL PETER C
Director · 970 股 · $227,688
Aug 07
Farrell Michael J.
Officer, Director · 4.99K 股 · $1.03M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 07
SC 13G: AustralianSuper Pty Ltd
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据